Further, the expression of Y239F Crk in Crk-null mouse embryonic fibroblasts, glioma and breast cancer led to a marked reduction in the speed of cell migration compared to the reconstitution with wild-type Crk [57]. The gene discussed is CRK; the disease is central nervous system cancer.